Wells Fargo’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$85.4K Buy
29,559
+7,065
+31% +$20.4K ﹤0.01% 4876
2025
Q1
$48.4K Buy
22,494
+2,837
+14% +$6.1K ﹤0.01% 4965
2024
Q4
$76.1K Buy
19,657
+6,701
+52% +$25.9K ﹤0.01% 4844
2024
Q3
$84.9K Sell
12,956
-513
-4% -$3.36K ﹤0.01% 4717
2024
Q2
$97.7K Buy
13,469
+4,041
+43% +$29.3K ﹤0.01% 4596
2024
Q1
$71.6K Buy
9,428
+1,433
+18% +$10.9K ﹤0.01% 4711
2023
Q4
$36.4K Buy
7,995
+1,565
+24% +$7.12K ﹤0.01% 4967
2023
Q3
$25.4K Sell
6,430
-3,365
-34% -$13.3K ﹤0.01% 5139
2023
Q2
$30.7K Buy
9,795
+9,595
+4,798% +$30K ﹤0.01% 5321
2023
Q1
$906 Buy
200
+3
+2% +$14 ﹤0.01% 6087
2022
Q4
$814 Buy
197
+99
+101% +$409 ﹤0.01% 5920
2022
Q3
$0 Buy
98
+20
+26% ﹤0.01% 6738
2022
Q2
$0 Buy
+78
New ﹤0.01% 6893
2021
Q1
Sell
-5,604
Closed -$120K 6763
2020
Q4
$120K Buy
5,604
+5,525
+6,994% +$118K ﹤0.01% 5132
2020
Q3
$1K Buy
79
+63
+394% +$797 ﹤0.01% 5854
2020
Q2
$0 Hold
16
﹤0.01% 6175
2020
Q1
$0 Buy
+16
New ﹤0.01% 6140
2019
Q4
Sell
-500
Closed -$4K 6088
2019
Q3
$4K Buy
500
+127
+34% +$1.02K ﹤0.01% 5679
2019
Q2
$6K Sell
373
-937
-72% -$15.1K ﹤0.01% 5593
2019
Q1
$43K Buy
1,310
+80
+7% +$2.63K ﹤0.01% 5261
2018
Q4
$73K Sell
1,230
-2
-0.2% -$119 ﹤0.01% 5152
2018
Q3
$173K Buy
1,232
+999
+429% +$140K ﹤0.01% 4890
2018
Q2
$29K Buy
+233
New +$29K ﹤0.01% 5436
2017
Q4
Sell
-500
Closed -$21K 5922
2017
Q3
$21K Buy
+500
New +$21K ﹤0.01% 5378
2017
Q2
Sell
-3,628
Closed -$203K 5881
2017
Q1
$203K Buy
3,628
+3,367
+1,290% +$188K ﹤0.01% 4633
2016
Q4
$10K Hold
261
﹤0.01% 5461
2016
Q3
$10K Hold
261
﹤0.01% 5447
2016
Q2
$19K Sell
261
-96
-27% -$6.99K ﹤0.01% 5243
2016
Q1
$28K Sell
357
-1,046
-75% -$82K ﹤0.01% 5201
2015
Q4
$105K Buy
1,403
+836
+147% +$62.6K ﹤0.01% 4707
2015
Q3
$217K Buy
567
+280
+98% +$107K ﹤0.01% 4276
2015
Q2
$119K Buy
287
+13
+5% +$5.39K ﹤0.01% 4779
2015
Q1
$130K Buy
274
+247
+915% +$117K ﹤0.01% 4485
2014
Q4
$10K Buy
+27
New +$10K ﹤0.01% 5398